Business Wire
09 Mar 2026, 20:05 UTC · 29w ago
Verdict
Headline takes no side. We score PRTA +1.00 — strongly bullish.
+1.00strongly bullish
More positive than 99% of ticker scores this week
Which stocks this story touches
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More positive than 56% of relationship scores this week
[mutual] Prothena received a milestone payment from Novo Nordisk for the Phase 3 CLEOPATTRA trial.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Proactive Investors
1h ago
−11.1%
Price is moving against the score
$8.72 vs $9.81 close before publication (Mar 9) · not market-adjusted
PRTA chart →
